Publications

 Complete listing of NA-ACCORD publications, presentations and reports is available here.
 
  1. Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at DiagnosisGrover S, Desir F, Jing Y, Bhatia RK, Trifiletti DM, Swisher-McClure S, Kobie J, Moore RD, Rabkin CS, Silverberg MJ, Salters K, Mathews WC, Gill MJ, Thorne JE, Castilho J, Kitahata MM, Justice A, Horberg MA, Achenbach CJ, Mayor AM, Althoff KN; North American AIDS Cohort Collaboration on Research and Design. J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):421-429. PMC620362
     
  2. One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United StatesDesir FA, Lesko CR, Moore RD, Horberg MA, Wong C, Crane HM, Silverberg M, Thorne JE, Rachlis B, Rabkin C, Mayor AM, Mathews WC, Althoff KN; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Region of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Consortium. Clin Infect Dis. 2018 Aug 31. PMCID in process
     
  3. Non-Hodgkin lymphoma risk in adults living with HIV across five continents: a multicohort study. AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord. AIDS. 2018 Sep 17. [Epub ahead of print]  PMCID in process
     
  4. Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men. Burger EA, Dyer MA, Sy S, Palefsky JM, de Pokomandy A, Coutlee F, Silverberg MJ, Kim JJ. J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):10-19. PMC6092220
     
  5. Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and CanadaYanik EL, Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Horberg MA, Moore RD, Mathews WC, Justice AC, Hessol NA, Mayor AM, Gill MJ, Brooks JT, Sun J, Althoff KN, Engels EA, Silverberg MJ, Dubrow R. J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):499-504. PMC6037538
     
  6. Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA).Giles ML, Achhra AC, Abraham AG, Haas AD, Gill MJ, Lee MP, Luque M, McGowan C, Cornell M, Braitstein P, de Rekeneire N, Becquet R, Wools-Kaloustian K, Law M.  J Int AIDS Soc. 2018 Jun;21(6):e25149. PMC6024257
     
  7. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. Tymejczyk O, Brazier E, Yiannoutsos CT, Wools-Kaloustian KK, Althoff KN, Crabtree-Ramirez B, Van Nguyen K, Zaniewski E, Dabis F, d'Amour Sinayobye J, Anderegg N, Ford N, Wikramanayake R, and Nash D, for the IeDEA Collaboration. PLoS Med. 2018 Mar 23;15(3):e1002534. PMC5865713
     
  8. Multimorbidity Among Persons Living with HIV in the U.S. Wong C, Gange SJ, Moore RD, Justice AC, Buchacz K, Abraham AG, Rebeiro PF, Koethe JR, Martin JN, Horberg MA, Boyd CM, Kitahata MM, Crane HM, Gebo KA, Gill MJ, Silverberg MJ, Palella FJ, Patel P, Samji H, Thorne J, Rabkin CS, Mayor A, Althoff KN. Clin Infect Dis. 2018 Apr 3;66(8):1230-1238. PMC5889007
     
  9. Recent abacavir use increases risk for Types 1 and 2 myocardial infarctions among adults with HIVElion RA, Althoff KN, Zhang J, Moore RD, Gange SJ, Kitahata MM, Crane HM, Drozd DR, Stein JH, Klein MB, Eron JJ, Silverberg MJ, Mathews WC, Justice AC, Sterling TR, Rabkin CS, Mayor AM, Klein DB, Horberg MA, Bosch RJ, Eyawo O, Palella FJ Jr; North American AIDS Cohort Collaboration on Research and Design of IeDEA. J Acquir Immune Defic Syndr. 2018 Feb 6. PMC5889316
     
  10. Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunitiesLesko CR, Jacobson LP, Althoff KN, Abraham AG, Gange SJ, Moore RD, Modur S, Lau B. Int J Epidemiol. 2018 Feb 8. PMC5913631
     
  11. Cancer burden attributable to cigarette smoking among HIV-infected people in North AmericaAltekruse SF, Shiels MS, Modur SP, Land SR, Crothers KA, Kitahata MM, Thorne JE, Mathews WC, Fernández-Santos DM, Mayor AM, Gill JM, Horberg MA, Brooks JT, Moore RD, Silverberg MJ, Althoff KN, Engels EA. AIDS. 2018 Feb 20;32(4):513-521. PMC5797998
     
  12. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment ProgramsIeDEA and COHERE Cohort Collaborations. Clin Infect Dis. 2018 Mar 5;66(6):893-903. PMC5848308
     
  13. HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA CollaborationJiamsakul A, Kariminia A, Althoff KN, Cesar C, Cortes CP, Davies MA, Do VC, Eley B, Gill J, Kumarasamy N, Machado DM, Moore R, Prozesky H, Zaniewski E, Law M. J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):319-329. PMC5634924
     
  14. Comparison of Kaposi sarcoma risk in HIV-positive adults across five continents: a multiregional multicohort studyBohlius J; AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord. Clin Infect Dis. 2017 Oct 15;65(8):1316-1326. PMC5850623
     
  15. Cancer-attributable mortality among people with treated HIV infection in North AmericaEngels EA, Yanik EL, Wheeler W, Gill MJ, Shiels MS, Dubrow R, Althoff KN, Silverberg MJ, Brooks JT, Kitahata MM, Goedert JJ, Grover S, Mayor AM, Moore RD, Park LS, Rachlis A, Sigel K, Sterling TR, Thorne JE, Pfeiffer RM. Clin Infect Dis. 2017 Aug 15;65(4):636-643. PMC5849088
     
  16. Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General PopulationDrozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, Burkholder GA, Mathews WC, Silverberg MJ, Sterling TR, Heckbert SR, Budoff MJ, Van Rompaey S, Delaney JAC, Wong C, Tong W, Palella FJ, Elion RA, Martin JN, Brooks JT, Jacobson LP, Eron JJ, Justice AC, Freiberg MS, Klein DB, Post WS, Saag MS, Moore RD, Crane HM. J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):568-576. PMC5522001
     
  17. A Flow-Based Model of the HIV Care Continuum in the United States. Gonsalves GS, Paltiel AD, Cleary PD, Gill MJ, Kitahata MM, Rebeiro PF, Silverberg MJ, Horberg M, Abraham AG, Althoff KN, Moore R, Bosch RJ, Hall HI, Kaplan EH. J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):548-553. PMC5533168
     
  18. All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. Anderegg N, Johnson LF, Zaniewski E, Althoff KN, Balestre E, Law M, Nash D, Shepherd BE, Yiannoutsos CT, Egger M; IeDEA, MeSH consortia. AIDS. 2017 Apr;31 Suppl 1:S31-S40. PMC5540664
     
  19. Risk of End Stage Renal Disease in HIV-positive Potential Live Kidney DonorsMuzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, Kitahata MM, Horberg MA, Justice AC, Fischer MJ, Silverberg MJ, Butt AA, Boswell SL, Rachlis AR, Mayor AM, Gill MJ, Eron JJ, Napravnik S, Drozd DR, Martin JN, Bosch RJ, Durand C, Locke JE, Moore RD, Lucas GM, Segev DL. Am J Transplant. 2017 Jul;17(7):1823-1832. PMC5489376
     
  20.  Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada.Dubrow R, Qin L, Lin H, Hernández-Ramírez RU, Neugebauer RS, Leyden W, Althoff KN, Achenbach CJ, Hessol NA, Modur SP, D'Souza G, Bosch RJ, Grover S, Horberg MA, Kitahata MM, Mayor AM, Novak RM, Rabkin CS, Sterling TR, Goedert JJ, Justice AC, Engels EA, Moore RD, Silverberg MJ. J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):382-390. PMC5490794
     
  21. Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada. Rebeiro PF, Abraham AG, Horberg MA, Althoff KN, Yehia BR, Buchacz K, Lau BM, Sterling TR, Gange SJ. AIDS Patient Care STDS. 2017 Mar;31(3):129-144 Epub 2017 Feb 27. PMC5359655
     
  22. First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013Wong C, Gange SJ, Buchacz K, Moore RD, Justice AC, Horberg MA, Gill MJ, Koethe JR, Rebeiro PF, Silverberg MJ, Palella FJ, Patel P, Kitahata MM, Crane HM, Abraham AG, Samji H, Napravnik S, Ahmed T, Thorne JE, Bosch RJ, Mayor AM, Althoff KN. Clin Infect Dis. 2017 Feb 15;64(4):459-467. PMC5850614
     
  23. HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers.Shiels MS, Althoff KN, Pfeiffer RM, Achenbach CJ, Abraham AG, Castilho J, Cescon A, D'Souza G, Dubrow R, Eron JJ, Gebo K, John Gill M, Goedert JJ, Grover S, Hessol NA, Justice A, Kitahata M, Mayor A, Moore RD, Napravnik S, Novak RM, Thorne JE, Silverberg MJ, Engels EA.  Clin Infect Dis. 2017 Feb 15;64(4):468-475. PMC5850313 
     
  24. Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.Fritz CQ, Blevins M, Lindegren ML, Wools-Kaloutsian K, Musick BS, Cornell M, Goodwin K, Addison D, Dusingize JC, Messou E, Poda A, Duda SN, McGowan CC, Law MG, Moore RD, Freeman A, Nash D, Wester CW.  J Int AIDS Soc. 2017 Jan 6;20(1):1-14. PMC5463912
     
  25. The Shifting Paradigm of Care for Adults Living With HIV: Smoking Cessation for Longer Life. Althoff KN. J Infect Dis. 2016 Dec 1;214(11):1618-1620. PMC5144730
     
  26. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. Buchacz K, Lau B, Jing Y, Bosch R, Abraham AG, Gill MJ, Silverberg MJ, Goedert JJ, Sterling TR, Althoff KN, Martin JN, Burkholder G, Gandhi N, Samji H, Patel P, Rachlis A, Thorne JE, Napravnik S, Henry K, Mayor A, Gebo K, Gange SJ, Moore RD, Brooks JT. J Infect Dis. 2016 Sep 15;214(6):862-72. PMC4996145
     
  27. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy ErasKlein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V 3rd, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, Peters MG, Goedert JJ, Mayor A, Thio CL, Cachay ER, Moore R; North American AIDS Cohort Collaboration on Research and Design of IeDEA. Clin Infect Dis. 2016 Nov 1;63(9):1160-1167. PMC5064164
     
  28. Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International ScaleRachlis B, Karwa R, Chema C, Pastakia S, Olsson S, Wools-Kaloustian K, Jakait B, Maina M, Yotebieng M, Kumarasamy N, Freeman A, de Rekeneire N, Duda SN, Davies MA, Braitstein P. Drug Saf. 2016 Oct;39(10):959-76. PMC5018020
     
  29. Higher Time-updated Body Mass Index: Association with Improved CD4+ Cell Recovery on HIV TreatmentKoethe JR, Jenkins CA, Lau B, Shepherd BE, Wester W, Rebeiro PF, Silverberg MJ, Thorne JE, Gill J, Mayor AM, Willig A, Bosch R, Horberg MA, Justice AC, Sterling TR, Moore RD. J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):197-204. PMC5023455
     
  30. Timing of Antiretroviral Treatment, Immunovirologic Status and TB Risk: Implications for Test and TreatPettit AC, Mendes A, Jenkins C, Napravnik S, Freeman A, Shepherd BE, Dowdy D, Gill J, Rachlis A, Moore R, Sterling TR; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) investigators of International epidemiologic Databases to Evaluate AIDS (IeDEA). J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):572-8. PMC4942351
     
  31. A Picture is Worth a Thousand Words: Maps of HIV Indicators to Inform Research, Programs, and Policy from NA-ACCORD and CCASAnet Clinical CohortsAlthoff KN, Rebeiro PF, Hanna DB, Padgett D, Horberg MA, Grinsztejn B, Abraham AG, Hogg R, Gill MJ, Wolff MJ, Mayor A, Rachlis A, Williams C, Sterling TR, Kitahata MM, Buchacz K, Thorne JE, Cesar C, Cordero FM, Rourke SB, Sierra-Madero J, Pape JW, Cahn P, McGowan C; North American Aids Cohort Collaboration on Research and Design (NA-ACCORD) and Caribbean, Central and South America Network for Hiv Epidemiology (CCASAnet). J Int AIDS Soc. 2016 Apr 4;19(1):20707.
    PMC4821890
     
  32. Health Outcomes Among HIV-Positive Latinos Initiating Antiretroviral Therapy in North America versus Central and South AmericaCesar C, Koethe JR, Giganti MJ, Rebeiro P, Althoff KN, Napravnik S, Mayor A, Grinsztejn B, Wolff M, Padgett D, Sierra-Madero J, Gotuzzo E, Sterling TR, Willig J, Levison J, Kitahata M, Rodriguez-Barradas MC, Moore RD, McGowan C, Shepherd BE, Cahn P; Caribbean, Central and South America Network for HIV epidemiology (CCASAnet) and North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). J Int AIDS Soc. 2016 Mar 18;19(1):20684. PMC4800379
     
  33. Geographic Variations in Retention in Care among HIV-Infected Adults in the United States. Rebeiro PF, Gange SJ, Horberg MA, Abraham AG, Napravnik S, Samji H, Yehia BR, Althoff KN, Moore RD, Kitahata MM, Sterling TR, Curriero FC; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). PLoS One. 2016 Jan 11;11(1):e0146119. PMC4708981
     
  34. Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. Rebeiro PF, Althoff KN, Lau B, Gill J, Abraham AG, Horberg MA, Kitahata MM, Yehia BR, Samji H, Brooks JT, Buchacz K, Napravnik S, Silverberg MJ, Rachlis A, Gebo KA, Sterling TR, Moore RD, Gange SJ; North American AIDS Cohort Collaboration on Research and Design. Am J Epidemiol. 2015 Dec 1;182(11):952-60. PMC4655744
     
  35. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and CanadaKoethe JR, Jenkins CA, Lau B, Shepherd BE, Justice AC, Tate JP, Buchacz K, Napravnik S, Mayor AM, Horberg MA, Blashill AJ, Willig A, Wester CW, Silverberg MJ, Gill J, Thorne JE, Klein M, Eron JJ, Kitahata MM, Sterling TR, Moore RD; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). AIDS Res Hum Retroviruses. 2016 Jan;32(1):50-8. PMC4692122
     
  36. Body Mass Index and Early CD4+ T-cell Recovery among Adults Initiating Antiretroviral Therapy in North America, 1998-2010Koethe JR, Jenkins CA, Lau B, Shepherd BE, Silverberg MJ, Brown TT, Blashill AJ, Anema A, Willig A, Stinnette S, Napravnik S, Gill MJ, Crane HM, Sterling TR. HIV Med. 2015 Oct;16(9):572-7. PMC4558259
     
  37. Cumulative Incidence of Cancer among HIV-infected Individuals in North America. Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D’Souza G, Engels EA, Hessol N, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P, Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD and Dubrow R for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Ann Intern Med. 2015 Oct 6;163(7):507-18. PMC4711936
     
  38. Feasibility and acceptability of developing a multi-site clinical cohort of transgender people with HIV infectionPoteat T, Hanna DB, Althoff KN. AIDS Res Hum Retroviruses. 2015 Sep;31(9):870-2. PMC4808270
     
  39. Ascertainment and verification of end-stage renal and liver disease in the North American AIDS Cohort Collaboration on Research and DesignKitahata MM, Drozd DR, Crane HM, Van Rompaey SE, Althoff KN, Gange SJ, Klein MB, Lucas GM, Abraham AG, Lo Re V, McReynolds J, Lober WB, Mendes A, Modur SP, Jing Y, Morton EJ, Griffith MA, Freeman AM and Moore RD. AIDS Res Treat. 2015; 2015:923194. Epub 2015 Feb 19. PMC4350581
     
  40. CD4+ T cell Recovery during Suppression of HIV Replication: a Global Comparison of the Immunologic Efficacy of Antiretroviral TherapyGeng EH, Neilands TB, Thièbaut R, Bwana MB, Nash D, Moore RD, Wood R, Zannou DM, Althoff KN, Lim PL, Nachega JB, Easterbrook PJ, Kambugu A, Little F, Nakigozi G, Nakanjako D, Kiggundu V, Ki Li PC, Bangsberg DR, Fox MP, Prozesky H, Hunt PW, Davies MA, Reynolds SJ, Egger M, Yiannoutsos CT, Vittinghoff EV, Deeks SG, Martin JN. Int J Epidemiol. 2015 Feb;44(1):251-63.  PMC4339766
     
  41. The Impact of Age on Retention in Care and Viral SuppressionYehia BR, Rebeiro PF, Althoff KN, Agwu AL, Horberg MA, Samji H, Napravnik S, Mayer KH, Tedaldi E, Silverberg MJ, Thorne JE, Burchell AN, Rourke SB, Rachlis A, Mayor A, Gill MJ, Zinski A, Ohl M, Anastos K, Abraham AG, Kitahata MM, Moore RD and Gebo KA; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):413-9. PMC4334738
     
  42. End Stage Renal Disease among HIV-Infected Adults in North America.  Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, Bosch RJ, Crane HM, Eron JJ, Gill MJ, Horberg MA, Justice AC, Klein MB, Mayor AM, Moore RD, Palella FJ, Parikh CR, Silverberg MJ, Golub ET, Jacobson LP, Napravnik S, Lucas GM; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Clin Infect Dis. 2015 Mar 15;60(6):941-9. PMC4357817
     
  43. Characteristics and Comprehensiveness of Adult HIV Care and Treatment Programmes in Asia-Pacific, Sub-Saharan Africa and the Americas: Results of a Site Assessment Conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration. J Int AIDS Soc. 2014 Dec 15;17:19045. PMC4268491Duda SN, Farr AM, Lindegren ML, Blevins M, Wester CW, Wools-Kaloustian K, Ekouevi DK, Egger M, Hemingway-Foday J, Cooper DA, Moore RD, McGowan CC, Nash D; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration. 
     
  44. Strong Agreement of Nationally Recommended Retention Measures from the Institute of Medicine and Department of Health and Human Services. Rebeiro PF, Horberg MA, Gange SJ, Gebo KA, Yehia BR, Brooks JT, Buchacz K, Silverberg MJ, Gill MJ, Moore RD, Althoff KN; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). PLoS One. 2014 Nov 6;9(11):e111772. PMC4222946
     
  45. Incidence and Risk Factors of HPV-Related and HPV-Unrelated Head and Neck Squamous Cell Carcinoma in HIV-Infected IndividualsBeachler DC, Abraham AG, Silverberg MJ, Jing Y, Fakhry C, Gill MJ, Dubrow R, Kitahata MM, Klein MB, Burchell AN, Korthuis PT, Moore RD, D'Souza G; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Oral Oncol. 2014 Dec;50(12):1169-76. PMC4253676
     
  46. Identifying the appropriate comparison group for HIV-infected individualsWong C, Althoff KN, Gange SJ. Curr Opin HIV AIDS. 2014 Jul;9(4):379-85. PMC4105851
     
  47. Disparities in the Quality of HIV Care when Using US Department of Health and Human Services IndicatorsAlthoff KN, Rebeiro PF, Brooks JT, Buchacz K, Gebo KA, Martin JN, Hogg RS, Thorne JE, Klein MB, Gill MJ, Sterling TR, Yehia BR, Silverberg MJ, Crane HM, Justice AC, Gange SJ, Moore RD, Kitahata MM, Horberg MA for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Clin Infect Dis. 2014 Apr;58(8):1185-9. PMC3967825
     
  48. Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries. Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F, Nash D, Gsponer T, Sungkanuparph S, McGowan C, May M, Cooper D, Chimbetete C, Wolff M, Collier A, McManus H, Davies MA, Costagliola D, Crabtree-Ramirez B, Chaiwarith R, Cescon A, Cornell M, Diero L, Phanuphak P, Sawadogo A, Ehmer J, Eholie SP, Li PC, Fox MP, Gandhi NR, González E, Lee CK, Hoffmann CJ, Kambugu A, Keiser O, Ditangco R, Prozesky H, Lampe F, Kumarasamy N, Kitahata MM, Lugina E, Lyamuya R, Vonthanak S, Fink V, d'Arminio Monforte A, Luz PM, Chen YM, Minga A, Casabona J, Mwango A, Choi JY, Newell ML, Bukusi EA, Ngonyani K, Merati TP, Otieno J, Bosco MB, Phiri S, Ng OT, Anastos K, Rockstroh J, Santos I, Oka S, Somi G, Stephan C, Teira R, Wabwire D, Wandeler G, Boulle A, Reiss P, Wood R, Chi BH, Williams C, Sterne JA, Egger M. J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e8-16. PMC3894575
     
  49. Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and CanadaSamji H, Cescon A, Hogg RS, Modur S, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, Justice AC, Kirk G, Klein MB, Korthuis PT, Martin J, Napravnik S, Rourke SB, Sterling TR, Silverberg MJ, Deeks S, Jacobson LP, Bosch RJ, Kitahata MM, Goedert JJ, Moore RD, Gange SJ for The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.  PLoS One. 2013 Dec 18;8(12):e81355. PMC3867319
     
  50. Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009.Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Collier A, Samji H, Thorne JE, Althoff KN, Martin JN, Rodriguez B, Stuart EA, Gange SJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). PLoS One. 2013 Nov 18;8(11):e78952. PMC3657490
     
  51. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individualsLucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA; NA-ACCORD of the IeDEA. J Infect Dis. 2013 Oct 15;208(8):1240-9. Epub 2013 Jul 31. PMC3778973
     
  52. Trends and Disparities in Antiretroviral Therapy Initiation and Virologic Suppression Among Newly Treatment-Eligible HIV-Infected Individuals in North America, 2001-2009. Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Lau B, Althoff KN, Crane HM, Collier AC, Samji H, Thorne JE, Gill MJ, Klein MB, Martin JN, Rodriguez B, Rourke SB, Gange SJ; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS. Clin Infect Dis. 2013 Apr;56(8):1174-82. PMC3657490
     
  53. Invasive cervical cancer risk among HIV-infected women: A North American multi-cohort collaboration prospective study. Abraham AG, Strickler HD, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, Saag MS, Rourke SB, Rachlis A, Napravnik S, Moore RD, Klein MB, Kitahata MM, Kirk G, Hogg RS, Hessol NA, Goedert JJ, Gill MJ, Gebo KA, Eron JJ, Engels EA, Dubrow R, Crane HM, Brooks JT, Bosch RJ, D'Souza G; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):405-13. PMC3633634
     
  54. Retention Among North American HIV-infected Persons in Clinical Care, 2000-2008. Rebeiro PF, Althoff KN, Buchacz K, Gill MJ, Horberg MA, Krentz H, Brooks JT, Gebo KA, Sterling TR, Moore RD, Mugavero MJ, Martin JN, Klein MB, Hogg RS, Silverberg MJ, Rourke SB, Thorne J and Gange SJ; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):356-62. PMC3661708
     
  55. Predictive Accuracy of the Veterans Aging Cohort Study (VACS) Index for Mortality with HIV Infection: A North American Cross Cohort Analysis. Justice AC, Modur S, Tate J, Althoff KN, Jacobson LP, Gebo KA, Kitahata MM, Horberg MA, Brooks JT, Buchacz K, Rourke SB, Rachlis A, Napravnik S, Eron JJ, Willig JH, Moore RD, Kirk GD, Bosch RJ, Rodriguez B, Hogg RS, Thorne JE, Goedert JJ, Klein MB, Gill MJ, Deeks SG, Sterling TR, Anastos K, Gange SJ; for the NA-ACCORD and VACS Project Teams. J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):149-63. PMC3619393
     
  56. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008Althoff KN, Buchacz K, Hall HI, Zhang J, Hanna DB, Rebeiro PF, Gange SJ, Moore RD, Kitahata MM, Gebo KA, Martin J, Justice AC, Horberg MA, Hogg RS, Sterling TR, Cescon A, Klein MB, Thorne JE, Crane HM, Mugavero MJ, Napravnik S, Kirk GD, Jacobson LP, Brooks JT; North American AIDS Cohort Collaboration on Research and Design. Ann Intern Med. 2012 Sep 4;157(5):325-35. PMC3534765
     
  57. Risk of Anal Cancer in HIV-Infected and HIV-uninfected Individuals in North AmericaSilverberg MJ, Lau B, Justice AC, Engels EA, Gill MJ, Goedert JJ, Kirk GD, D’Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, Moore RD, Rodriguez B, Rourke SB, Saag MS, Sterling TR, Gebo KA, Press N, Martin JN, Dubrow R, for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Clin Infect Dis 2012 54(7):1026-34. PMC3297645
     
  58. Risk Factors for Tuberculosis After Highly Active Antiretroviral Therapy Initiation in the United States and Canada: Implications for Tuberculosis Screening.Sterling TR, Lau B, Zhang J, Freeman AM, Bosch RJ, Brooks JT, Deeks SG, French A, Gange SJ, Gebo KA, Gill MJ, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Klein MB, Martin JN, Rodriguez, B, Silverberg MJ, Willig JH, Eron JJ, Goedert JJ, Hogg RS, Justice AC, McKaig RG, Napravnik S, Thorne J, Moore RD, for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.  J Infect Dis. 2011 204: 893-901. PMC3156918
     
  59. Missing Data on the Estimation of the Prevalence of Accumulated Human Immunodeficiency Virus Drug Resistance in Patients Treated With Antiretroviral Drugs in North AmericaAbraham AG, Lau B, Deeks S, Moore RD, Zhang J, Eron JJ, Harrigan R, Gill MJ, Kitahata MM, Klein MB, Napravnik S, Rachlis A, Rodriguez B, Rourke SB, Benson C, Bosch RJ, Collier A, Gebo KA, Goedert JJ, Hogg RS, Horberg MA, Jacobson LP, Justice AC, Kirk GD, Martin JN, McKaig RG, Silverberg MJ, Sterling TR, Thorne JE, Willig JH, Gange SJ. Am J Epidemiol. 2011 Sep 15;174(6):727-35. PMC21813792
     
  60. Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entryLau B, Cole SR, Gange SJ.  Stat Med. 2011 Mar 15;30(6):654-65. PMC21337360
     
  61. CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation? Althoff KN, Gebo KA, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Eron JJ, Napravnik S, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Deeks SG, Martin JN, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Goedert JJ, McKaig RG, Thorne J, Rachlis A, Moore RD, Justice AC; for the North American AIDS Cohort Collaboration on Research and Design. AIDS Res Ther. 2010 Dec 15;7(1):45. PMC3022663
     
  62. Virologic and immunologic response to HAART, by age and regimen classAlthoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein MB, Gebo KA; for the North American AIDS Cohorts Collaboration on Research, Design (NA-ACCORD). AIDS. 2010 Oct 23;24(16):2469-79. PMC20829678
     
  63. When to start antiretroviral therapyKitahata MM. Top HIV Med. 2010 Aug-Sep;18(3):121-6. PMC20921578
     
  64.  Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional studyLau B, Chander G, Gange SJ, Moore RD.AIDS Res Ther. 2010 Jul 23;7:25. PMC2922076
     
  65. Late Presentation for HIV Care in the United States and Canada. Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Deeks SG, Martin JN, Rachlis AR, Napravnik S, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Goedert JJ, McKaig RG, Van Rompaey SE, Zhang J. Moore RD. Clin Infect Dis. 2010 Jun 1;50(11):1512-20. PMC2862849
     
  66. Trends in Multi-Drug Failure and Subsequent Mortality among Antiretroviral Therapy-Experienced HIV-Infected Patients in North AmericaDeeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Kushel MB, Goedert JJ, McKaig RG, Moore RD for the North American AIDS Cohort Collaboration on Research and Design. Clin Infect Dis. 2009 Nov: 49 (10): 1582–1590. PMC2871149
     
  67. Effect of early versus delayed antiretroviral therapy for HIV on survivalKitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD, for the NA-ACCORD. N Engl J Med. 2009;360:1815-1826. [With Editorial Commentary]. PMC2854555
     
  68. Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies.Lau B, Gange SJ, Kirk GD, and Moore RD. Epidemiology 2009 20(5):664-72. PMC2818534
     
  69. Competing risk regression models for epidemiologic data.  Lau B, Cole SR, and Gange SJ. Am J Epidemiol 2009 Jul 15;170(2):244-56. PMC2732996
     
  70. Evaluating competing adverse and beneficial outcomes using a mixture modelLau B, Cole SR, Moore RD, Gange SJ. Statistics in Medicine 2008;27(21):4313-27. PMC2251745
     
  71.  Interval and clinical cohort studies: epidemiological issues. Lau B, Gange SJ, Moore RD. AIDS Res Hum Retroviruses. 2007 Jun;23(6):769-76. PMC 17604539
     
  72. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, Brooks JT, Calzavara L, Deeks SG, Eron JJ, Gebo KA, Gill MJ, Haas DW, Hogg RS, Horberg MA, Jacobson LP, Justice AC, Kirk GD, Klein MB, Martin JN, McKaig RG, Rodriguez B, Rourke SB, Sterling TR, Freeman AM, Moore RD. Int J Epidemiol. 2007 Apr;36(2):294-301. PMC2820873

 

Files: 
AttachmentSize
NA-ACCORD_Dossier_20181107.docx178.04 KB